Загрузка...
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre
INTRODUCTION: According to recent evidence about boosted protease inhibitors (PIs/r)-simplified regimens, the combination of 3TC and DRV/r 800/100 mg could represent a feasible option for optimizing antiretroviral therapy (ART) in treatment-experienced HIV+ patients. PATIENTS AND METHODS: We retrosp...
Сохранить в:
| Опубликовано в: : | J Int AIDS Soc |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International AIDS Society
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225243/ https://ncbi.nlm.nih.gov/pubmed/25397561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19817 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|